Published in J Nucl Med on March 01, 2003
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging (2008) 3.24
Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging (2004) 1.48
Is PET-CT the only option? Eur J Nucl Med Mol Imaging (2007) 1.48
PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging (2005) 1.14
Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol (2012) 1.00
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development. Eur Radiol (2009) 0.93
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging (2006) 0.93
PET/CT in oncology: for which tumours is it the reference standard? Cancer Imaging (2007) 0.90
Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging. Eur J Nucl Med Mol Imaging (2012) 0.88
Use of segmented CT transmission map to avoid metal artifacts in PET images by a PET-CT device. BMC Nucl Med (2005) 0.87
Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT. Eur Radiol (2009) 0.87
PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging (2003) 0.86
PET/CT artifacts. Clin Imaging (2011) 0.86
Oral contrast medium in PET/CT: should you or shouldn't you? Eur J Nucl Med Mol Imaging (2005) 0.82
Artefacts of PET/CT images. Biomed Imaging Interv J (2006) 0.79
Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations. Cancer Imaging (2007) 0.77
Calcified Lymph Nodes Causing Clinically Relevant Attenuation Correction Artifacts on PET/CT Imaging. J Radiol Case Rep (2010) 0.77
Utility of negative oral contrast (milk with 4% fat) in PET-CT studies. Indian J Nucl Med (2012) 0.75
Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol (2008) 4.70
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol (2009) 4.53
Neural systems and cue-induced cocaine craving. Neuropsychopharmacology (2002) 3.50
131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med (2005) 3.38
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med (2003) 3.15
Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol (2008) 3.14
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol (2006) 3.01
Median arcuate ligament syndrome: evaluation with CT angiography. Radiographics (2005) 3.00
Splenic artery aneurysms and pseudoaneurysms: clinical distinctions and CT appearances. AJR Am J Roentgenol (2007) 3.00
Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med (2004) 3.00
Recent progress in pancreatic cancer. CA Cancer J Clin (2013) 2.88
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med (2003) 2.61
Radiology education in 2005: world wide web practice patterns, perceptions, and preferences of radiologists. Radiographics (2007) 2.47
"USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med (2003) 2.45
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet (2012) 2.44
Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations. Circulation (2002) 2.42
Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis (2007) 2.42
Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J Am Coll Cardiol (2008) 2.33
CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease. Radiographics (2003) 2.25
Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol (2009) 2.20
The CT scout view: does it need to be routinely reviewed as part of the CT interpretation? AJR Am J Roentgenol (2014) 2.08
Adrenal imaging with MDCT: Nonneoplastic disease. AJR Am J Roentgenol (2009) 2.05
Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. AJR Am J Roentgenol (2015) 2.00
Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey. J Nucl Med (2011) 1.95
Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. J Nucl Med (2003) 1.95
EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc (2010) 1.91
Multi-detector row and volume-rendered CT of the normal and accessory flow pathways of the thoracic systemic and pulmonary veins. Radiographics (2002) 1.90
Multidetector row CT of superior mesenteric artery syndrome. J Clin Gastroenterol (2007) 1.88
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med (2006) 1.86
Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. J Nucl Med (2005) 1.83
Superior vena cava obstruction evaluation with MDCT. AJR Am J Roentgenol (2010) 1.82
18F-FDG PET/CT in evaluating non-CNS pediatric malignancies. J Nucl Med (2007) 1.79
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia (2005) 1.78
Castleman disease: the great mimic. Radiographics (2011) 1.75
Multi-detector row CT evaluation of living renal donors prior to laparoscopic nephrectomy. Radiographics (2004) 1.74
Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy. J Clin Oncol (2003) 1.74
Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. J Nucl Med (2007) 1.73
Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med (2005) 1.72
Comparison of 180 degrees and 360 degrees acquisition for myocardial perfusion SPECT with compensation for attenuation, detector response, and scatter: Monte Carlo and mathematical observer results. J Nucl Cardiol (2006) 1.72
Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol (2005) 1.71
CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med (2010) 1.70
CT after pancreaticoduodenectomy: spectrum of normal findings and complications. AJR Am J Roentgenol (2013) 1.68
Multi-detector row CT of pancreatic islet cell tumors. Radiographics (2006) 1.67
Internet-based dissemination of educational audiocasts: a primer in podcasting--how to do it. AJR Am J Roentgenol (2006) 1.67
Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. J Am Coll Surg (2009) 1.67
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med (2003) 1.64
Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics (2003) 1.64
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol (2006) 1.62
Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med (2012) 1.62
Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol (2007) 1.62
Soft-tissue masses and masslike conditions: what does CT add to diagnosis and management? AJR Am J Roentgenol (2010) 1.62
Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology (2005) 1.61
Low profile pelvic fixation: anatomic parameters for sacral alar-iliac fixation versus traditional iliac fixation. Spine (Phila Pa 1976) (2009) 1.60
Acinar cell carcinoma of the pancreas: computed tomography features--a study of 15 patients. Abdom Imaging (2013) 1.59
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol (2002) 1.59
Comparison of uptake of multiple clinical radiotracers into brown adipose tissue under cold-stimulated and nonstimulated conditions. J Nucl Med (2007) 1.56
Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic aortic ulcer. AJR Am J Roentgenol (2003) 1.55
Volume-rendered 3D CT of the mesenteric vasculature: normal anatomy, anatomic variants, and pathologic conditions. Radiographics (2002) 1.55
Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT. J Nucl Med (2009) 1.54
Role of computed tomography and magnetic resonance imaging in assessment of acute aortic syndromes. Semin Ultrasound CT MR (2003) 1.54
Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging (2004) 1.54
Assessment of local public health workers' willingness to respond to pandemic influenza through application of the extended parallel process model. PLoS One (2009) 1.53
18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy. J Nucl Med (2009) 1.53
MDCT of the abdomen: common misdiagnoses at a busy academic center. AJR Am J Roentgenol (2010) 1.53
Typical and atypical presentations of extramedullary hemopoiesis. AJR Am J Roentgenol (2002) 1.52
Do high-resolution CT findings of usual interstitial pneumonitis obviate lung biopsy? Views of pulmonologists. Respiration (2005) 1.51
Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry. Eur J Nucl Med Mol Imaging (2014) 1.51
A five-step approach to digital image manipulation for the radiologist. Radiographics (2002) 1.50
Differentiation of kidney stones using dual-energy CT with and without a tin filter. AJR Am J Roentgenol (2012) 1.49
Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology (2011) 1.48
The iPad as a mobile device for CT display and interpretation: diagnostic accuracy for identification of pulmonary embolism. Emerg Radiol (2012) 1.47
Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am J Roentgenol (2004) 1.47
Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med (2011) 1.45
Pretest risk assessment in suspected acute pulmonary embolism. Acad Radiol (2008) 1.44
A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy. J Nucl Med (2002) 1.42
Availability, requesting practices, and barriers to referral for high-resolution CT of the lungs: results of a survey of U.S. pulmonologists. Acad Radiol (2002) 1.39
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol (2006) 1.37
PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med (2002) 1.37
Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics (2009) 1.36
Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas. J Clin Oncol (2005) 1.35
A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas (2014) 1.35
Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg (2004) 1.34
Promise and pitfalls of quantitative imaging in oncology clinical trials. Magn Reson Imaging (2012) 1.34
Applying risk perception theory to public health workforce preparedness training. J Public Health Manag Pract (2005) 1.32
Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg (2007) 1.31
Three-class ROC analysis--a decision theoretic approach under the ideal observer framework. IEEE Trans Med Imaging (2006) 1.31